TY - JOUR
T1 - Surgical Management of Renal Cell Carcinoma
AU - Leibovich, Bradley C.
AU - Blute, Michael L.
PY - 2006/10
Y1 - 2006/10
N2 - Renal cell carcinoma (RCC) is a relatively rare malignancy, although the incidence appears to be increasing. RCC remains resistant to chemotherapy and curative therapy is limited to surgical resection of localized tumors. Recently there has been an expansion of the indications for nephron sparing approaches to patients with localized tumors. Likewise, the management of locally advanced tumors and the indications for cytoreductive surgery in the setting of metastatic RCC have been clarified by recent studies. Herein, we discuss the role of surgery for the management of localized and metastatic RCC.
AB - Renal cell carcinoma (RCC) is a relatively rare malignancy, although the incidence appears to be increasing. RCC remains resistant to chemotherapy and curative therapy is limited to surgical resection of localized tumors. Recently there has been an expansion of the indications for nephron sparing approaches to patients with localized tumors. Likewise, the management of locally advanced tumors and the indications for cytoreductive surgery in the setting of metastatic RCC have been clarified by recent studies. Herein, we discuss the role of surgery for the management of localized and metastatic RCC.
UR - http://www.scopus.com/inward/record.url?scp=33749446478&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33749446478&partnerID=8YFLogxK
U2 - 10.1053/j.seminoncol.2006.06.007
DO - 10.1053/j.seminoncol.2006.06.007
M3 - Article
C2 - 17045084
AN - SCOPUS:33749446478
SN - 0093-7754
VL - 33
SP - 552
EP - 562
JO - Seminars in oncology
JF - Seminars in oncology
IS - 5
ER -